Inhatarget Therapeutics (SRL)
Active
VAT
BE 0732.994.752
Address
Rue Antoine de Saint-Exupéry 2
6041
Charleroi
Established
29-08-2019
Principal activity
Research and experimental development on biotechnology
Crisis resilience of Inhatarget Therapeutics
Which companies are best armed against current economic trends and the energy crisis?
Read moreFinancial data of Inhatarget Therapeutics
2022
|
2021
|
2020
|
|||
|---|---|---|---|---|---|
| Profit/Loss | -€1,548,731 | -54% |
-€1,005,870 | -68% |
-€597,083 |
| Equity | €3,841,043 | 88% |
€2,046,554 | -33% |
€3,053,993 |
| Gross margin | €186,626 | 47% |
€127,384 | 251% |
-€84,604 |
| Employees | 6 FTE | 76% |
3,4 FTE | 21% |
2,8 FTE |
Publications in the Belgian Official Journal for Inhatarget Therapeutics
Frequently asked questions
What is the VAT number of Inhatarget Therapeutics?
The VAT number of Inhatarget Therapeutics is BE0732994752.
When was Inhatarget Therapeutics founded?
Inhatarget Therapeutics was founded on 29-08-2019.
What is the address of Inhatarget Therapeutics?
The current registered office of Inhatarget Therapeutics is located at Rue Antoine de Saint-Exupéry 2, 6041 Charleroi.
When was the last time Inhatarget Therapeutics filed their annual financial statements?
The most recent financial statements of Inhatarget Therapeutics were filed on 29-06-2023. You can view them here.
How many employees does Inhatarget Therapeutics have?
There are 6 FTEs working at Inhatarget Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Inhatarget Therapeutics?
At the time of its most recent financial statements, Inhatarget Therapeutics did not publish any turnover figures. Inhatarget Therapeutics reported a gross margin of €186,626.34.
